10X Genomics Inc (TXG) — Free Cash Flow Generation Index

Latest as of June 2026: 0.91x

10X Genomics Inc (TXG) has a Free Cash Flow Generation Index of 0.91x as of June 2026. Free cash flow of $15.39 Million represents 1% of operating cash flow ($16.97 Million). Explore 10X Genomics Inc capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.

FCF Generation Index

0.91x
Free Cash Flow / Operating CF

Free Cash Flow

$15.39 Million
USD

Operating Cash Flow

$16.97 Million
USD

Capital Expenditures

$1.59 Million
USD

10X Genomics Inc Free Cash Flow Generation Index (2019–2025)

Historical FCF Generation Index trend for 10X Genomics Inc across 3 annual periods. For the full cash flow conversion analysis, see 10X Genomics Inc operating cash flow efficiency.

Annual Free Cash Flow Generation for 10X Genomics Inc (2019–2025)

Year-by-year Free Cash Flow Generation Index for 10X Genomics Inc. Check 10X Genomics Inc investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Year FCG Index Free Cash Flow (USD) Operating CF Capital Expenditures YoY Change
2025 0.96x $130.12 Million $136.05 Million $5.93 Million ▲ +211.2%
2024 -0.86x $-5.73 Million $6.66 Million $12.39 Million ▼ -265.7%
2019 -0.24x $-8.14 Million $34.63 Million $42.77 Million
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).